- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01184937
Effect of Patient Education on Kidney Recipients Knowledge, Coping and Quality of Life
December 2, 2014 updated by: Oslo Metropolitan University
Effect of Patient Education on Kidney Recipients Knowledge, Coping and Quality of Life. A Randomized Controlled Trial.
For patients with end-stage kidney disease, transplantation is the treatment of choice, offering improved quality of life by restored metabolism and freedom from dialysis.
However, demands regarding the acquirement of knowledge in life post transplantation are high.
In order to reduce rejection episodes, graft loss and the negative consequences of life-long immunosuppressive medication, it is essential for kidney recipients to possess knowledge about important aspects regarding immunosuppressive medication, graft surveillance and the benefit of specific lifestyle behavior.
Consequently, patient education is required for this patient group.
This randomized controlled trial is investigating the effect of a structured patient education program on kidney recipients' knowledge, coping and quality of life
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
159
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oslo, Norway
- Oslo University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- being over 18
- recently had a kidney transplant
- able to speak, understand and read Norwegian
- mentally able to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard care
|
|
|
Experimental: Patient education program
|
All patients receive standard care.
Experimental group receive a structured patient education program based in self-care theory and pedagogical theory, build upon the the principles of the "Pro-Self education program".
The intervention program consist of five weekly one-to-one sessions with a transplant nurse, lasting about 40-60 minutes, starting during the first week after discharge and lasting until 7 weeks post transplantation.
Education content consists of two levels: general knowledge level and individual knowledge.
Each session has a specific program.
In addition, academic detailing is used to describe patient's knowledge levels and for tailoring the education to individual needs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kidney recipients'knowledge level
Time Frame: 7-8 weeks post kidney transplantation
|
Knowledge level is measured by a self-administrated knowledge questionnaire consisting of 19 items addressing knowledge in relation to three areas: medication, rejection and lifestyle.
Each item is rated using a 5 points scale, anchored on the left with the wording "totally disagree"(1), "rather disagree" (2) "either agree or disagree" (3), "quite agree" (4) and to the left with "totally agree"(5).
Patients are asked to put a ring around a number to indicate their level of agreement with each item.
|
7-8 weeks post kidney transplantation
|
|
Kidney recipients'knowledge level
Time Frame: 6 months post kidney transplantation
|
Knowledge level is measured by a self-administrated knowledge questionnaire consisting of 19 items addressing knowledge in relation to three areas: medication, rejection and lifestyle.
Each item is rated using a 5 points scale, anchored on the left with the wording "totally disagree"(1), "rather disagree" (2) "either agree or disagree" (3), "quite agree" (4) and to the left with "totally agree"(5).
Patients are asked to put a ring around a number to indicate their level of agreement with each item.
|
6 months post kidney transplantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kidney recipients' coping
Time Frame: 7-8 weeks post kidney transplantation
|
Coping is measured by the following self-administrated questionnaires: "The Generalized Self-efficacy Scale", "The Long-term Medication Behavior Self-efficacy Scale" and "The Moriscy Compliance scale".
In addition, the number of missing observations in the patients' "transplant diaries" is counted.(The
"transplant diary" contains patients own daily observations of graft function and signs of rejection).
Number of missing observations are counted from observation start and during a period of 7-8 weeks.
The percent of missed observations of total possible observations are estimated.
|
7-8 weeks post kidney transplantation
|
|
Kidney recipients' coping
Time Frame: 6 months post kidney transplantation
|
Coping is measured by the following self-administrated questionnaires: "The Generalized Self-efficacy Scale", "The Long-term Medication Behavior Self-efficacy Scale" and "The Moriscy Compliance scale".
|
6 months post kidney transplantation
|
|
Kidney recipients' quality of life
Time Frame: 7-8 weeks post kidney transplantation
|
Quality of life is measured by the following self -adminstred questionnaires: The acute version of the "Short Form Health Survey" (SF-12) and the disease-spesific quality of life questionnaire: "The Kidney Transplant Questionnaire"
|
7-8 weeks post kidney transplantation
|
|
Kidney recipients' quality of life
Time Frame: 6 months post kidney transplantation
|
Quality of life is measured by the following self -adminstred questionnaires: The acute version of the "Short Form Health Survey" (SF-12) and the disease-spesific quality of life questionnaire: "The Kidney Transplant Questionnaire"
|
6 months post kidney transplantation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (Actual)
November 1, 2009
Study Completion (Actual)
November 1, 2009
Study Registration Dates
First Submitted
June 25, 2010
First Submitted That Met QC Criteria
August 18, 2010
First Posted (Estimate)
August 19, 2010
Study Record Updates
Last Update Posted (Estimate)
December 3, 2014
Last Update Submitted That Met QC Criteria
December 2, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 182014/V52
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Recipients
-
Astellas Pharma China, Inc.CompletedRenal Transplant RecipientsChina
-
Georgetown UniversityTerminatedRenal Transplant RecipientsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedRenal Allograft Recipients
-
Agency for Healthcare Research and Quality (AHRQ)Unknown
-
Hacettepe UniversityRecruitingRenal Transplanted RecipientsTurkey
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)TerminatedRenal Transplant RecipientsUnited States
-
Novartis PharmaceuticalsCompletedRenal Transplanted RecipientsAustralia
-
Montefiore Medical CenterTerminated
-
Universidade Federal de PernambucoUnknownRenal Transplant RecipientsBrazil
-
Lawson Health Research InstituteAstellas Pharma Canada, Inc.CompletedRenal Transplant RecipientsCanada
Clinical Trials on Patient education program
-
Wen-Shao LinNational Taipei University of Nursing and Health Sciences; Cheng Hsin Rehabilitation...Active, not recruitingScleroderma, SystemicTaiwan
-
Karolinska InstitutetCompletedFunctional Gastrointestinal DisordersSweden
-
Hospices Civils de LyonCompletedHypermobility Type Ehlers-Danlos SyndromeFrance
-
Oslo University HospitalStiftelsen Helse og RehabiliteringCompletedChronic Fatigue Syndrome | Patient Education | CopingNorway
-
University Hospital, LinkoepingLinkoeping University; Sormland County Council, SwedenCompleted
-
Oslo University HospitalUnknownHip OsteoarthritisNorway
-
Ullevaal University HospitalUnknownExercise Therapy and Patient Education for Individuals With Hip Osteoarthritis. Long-term Follow-up.Hip OsteoarthritisNorway
-
Chang Gung Memorial HospitalWithdrawnMusic Therapy, Breast Cancer, Anxiety, FatigueTaiwan
-
Revmatismesykehuset ASCompleted
-
Ain Shams UniversityActive, not recruiting